日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CETSA-MS unveils novel targets engaged by rigosertib to promote anti-tumor activity and inflammatory responses.

CETSA-MS 揭示了 rigosertib 促进抗肿瘤活性和炎症反应的新靶点

Kechagioglou Petros, Yurugi Hajime, Dupont Camille, Chernobrovkin Alexey, Romero Rossana, Harms Gregory, Oster Marie, Ciesek Sandra, Tweedell Rebecca, Kanneganti Thirumala-Devi, Zimmer Stefanie, Cosenza Stephen, Fruchtman Steven M, Rajalingam Krishnaraj

Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia

使用多激酶抑制剂 ON108110 靶向蛋白激酶 CK2 和 CDK4/6 通路可抑制套细胞淋巴瘤和 T 细胞急性淋巴细胞白血病中的促生存信号传导和细胞生长。

Padgaonkar, Amol; Rechkoblit, Olga; Vasquez-Del Carpio, Rodgrigo; Pallela, Venkat; Venkata Subbaiah, Drc; Cosenza, Stephen C; Baker, Stacey J; Ramana Reddy, M V; Aggarwal, Aneel; Reddy, E Premkumar

Germ line transmission of the Cdk4(R24C) mutation facilitates tumorigenesis and escape from cellular senescence

Cdk4(R24C)突变的种系遗传促进肿瘤发生和细胞衰老逃逸。

Rane, Sushil G; Cosenza, Stephen C; Mettus, Richard V; Reddy, E Premkumar